Building the biopharma company of the futureAt PureTech Health, we are harnessing the latest insights from human biology to develop new categories of medicine. Our goal is to improve and extend the lives of patients by unlocking the biological processes associated with the brain-immune-gut interface (or the "BIG" axis). Our team of biopharma pioneers and entrepreneurs and our seasoned board are pursuing cutting edge science to move medicine forward. For more information, visit www.puretechhealth.com or connect with us on Twitter @PureTechh.
15
Total Investments
9
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Biotechnology, Finance +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About PureTech Health
Recent Investments (15)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Apr 2024 | |
| Series B | •••••• | Dec 2022 | |
| Series D | •••••• | Jul 2021 | |
| Series B | •••••• | Jul 2020 | |
| Series B | •••••• | Mar 2019 | |
|
|
Series A | •••••• | Aug 2018 |
|
|
Private Equity Round | •••••• | Jun 2016 |
|
|
Series B | •••••• | Jan 2016 |
|
|
Series A | •••••• | Apr 2015 |
|
|
Series B | •••••• | Jan 2011 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.